CRIS Current Research Information System

MONTANARO, LORENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.616
AS - Asia 5.176
EU - Europa 4.054
AF - Africa 354
Continente sconosciuto - Info sul continente non disponibili 339
SA - Sud America 271
OC - Oceania 17
Totale 16.827
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.495
CN - Cina 1.485
SG - Singapore 1.338
VN - Vietnam 1.331
IT - Italia 1.124
GB - Regno Unito 728
DE - Germania 437
SE - Svezia 433
HK - Hong Kong 307
FR - Francia 232
IN - India 200
BR - Brasile 193
RU - Federazione Russa 185
NL - Olanda 164
TG - Togo 142
UA - Ucraina 133
IE - Irlanda 125
KR - Corea 97
JP - Giappone 88
CA - Canada 80
CH - Svizzera 79
BD - Bangladesh 75
ZA - Sudafrica 68
HR - Croazia 67
CI - Costa d'Avorio 65
FI - Finlandia 61
EE - Estonia 59
AT - Austria 44
JO - Giordania 42
PL - Polonia 36
PH - Filippine 35
BE - Belgio 34
BG - Bulgaria 33
AR - Argentina 25
ID - Indonesia 24
TH - Thailandia 24
TW - Taiwan 22
DK - Danimarca 18
IQ - Iraq 17
TR - Turchia 17
SC - Seychelles 16
DZ - Algeria 15
AU - Australia 14
MX - Messico 14
EC - Ecuador 12
NG - Nigeria 11
EG - Egitto 10
GR - Grecia 10
IL - Israele 10
PK - Pakistan 10
CO - Colombia 9
SK - Slovacchia (Repubblica Slovacca) 9
TN - Tunisia 9
PY - Paraguay 8
RO - Romania 8
VE - Venezuela 8
ES - Italia 7
JM - Giamaica 7
KE - Kenya 7
SA - Arabia Saudita 7
IR - Iran 6
MY - Malesia 6
UZ - Uzbekistan 6
XK - ???statistics.table.value.countryCode.XK??? 6
CR - Costa Rica 5
MA - Marocco 5
SV - El Salvador 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
CL - Cile 4
CZ - Repubblica Ceca 4
LB - Libano 4
LT - Lituania 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BA - Bosnia-Erzegovina 3
HU - Ungheria 3
KW - Kuwait 3
LV - Lettonia 3
PE - Perù 3
UY - Uruguay 3
AM - Armenia 2
BB - Barbados 2
CY - Cipro 2
GT - Guatemala 2
KG - Kirghizistan 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
YE - Yemen 2
AD - Andorra 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AZ - Azerbaigian 1
BY - Bielorussia 1
ET - Etiopia 1
GA - Gabon 1
GY - Guiana 1
HN - Honduras 1
Totale 16.478
Salva come PNG Salva come JPEG
Città #
Singapore 946
Ashburn 655
Southend 608
Fairfield 541
Chandler 483
Bologna 328
Ann Arbor 316
Dallas 294
Woodbridge 287
San Jose 284
Ho Chi Minh City 277
Hong Kong 274
Houston 269
Santa Clara 254
Seattle 239
Wilmington 232
Hanoi 206
Dong Ket 201
Hefei 189
Cambridge 185
Beijing 159
Princeton 154
Lomé 142
Boardman 133
Council Bluffs 127
Dublin 125
New York 108
Milan 107
Los Angeles 101
Nanjing 90
Seoul 82
Lauterbourg 81
Jacksonville 72
Padova 72
Bern 69
Westminster 68
Tokyo 66
Abidjan 65
Berlin 55
Redwood City 55
Helsinki 48
Jinan 48
Da Nang 46
Shenyang 45
Amman 41
Hebei 40
Turin 40
Buffalo 39
Guangzhou 39
Shanghai 38
Frankfurt am Main 36
Brussels 33
Sofia 33
Vienna 33
Haiphong 32
Phoenix 32
Saint Petersburg 32
Warsaw 32
Redondo Beach 29
Bremen 28
São Paulo 28
San Diego 27
Chicago 26
Tianjin 26
Changsha 25
Florence 24
Falkenstein 23
Zhengzhou 23
Rome 22
Haikou 21
London 20
Nanchang 20
Sherbrooke 20
Jiaxing 19
Verona 19
Brooklyn 18
Montreal 18
Rimini 17
Hải Dương 16
Ningbo 16
Norwalk 16
The Dalles 16
Mülheim 15
Orem 15
Toronto 15
Wayne 15
Bengaluru 14
Dearborn 14
Modena 14
Olalla 14
Redmond 14
Atlanta 13
Copenhagen 13
Nuremberg 13
Xi'an 13
Des Moines 12
Falls Church 12
Hangzhou 12
Hyderabad 12
Shenzhen 12
Totale 10.445
Salva come PNG Salva come JPEG
Nome #
Combined expression levels of KDM2A and KDM2B correlate with nucleolar size and prognosis in primary breast carcinomas 307
STK11 mutations correlate with poor prognosis for advanced NSCLC treated with first-line immunotherapy or chemo-immunotherapy according to KRAS, TP53, KEAP1, and SMARCA4 status 296
The pre-existing population of 5S rRNA effects p53 stabilization during ribosome biogenesis inhibition 287
Human dyskerin binds to cytoplasmic H/ACA-box-containing transcripts affecting nuclear hormone receptor dependence 264
DKC1 Overexpression Induces a More Aggressive Cellular Behavior and Increases Intrinsic Ribosomal Activity in Immortalized Mammary Gland Cells 261
CLINICOPATHOLOGICAL, MOLECULAR AND ONCOLOGICAL FEATURES OF SPORADIC EARLY ONSET COLORECTAL CANCERS 257
A reconstituted cell-free assay for the evaluation of the intrinsic activity of purified human ribosomes 255
Therapeutic dosages of aspirin counteract the IL-6 induced pro-tumorigenic effects by slowing down the ribosome biogenesis rate 253
Carnitine-acyltransferase system inhibition, cancer cell death, and prevention of myc-induced lymphomagenesis. 249
Human ribosomes from cells with reduced dyskerin levels are intrinsically altered in translation 248
The nucleolar size is associated to the methylation status of ribosomal DNA in breast carcinomas. 238
Different effects of ribosome biogenesis inhibition on cell proliferation in retinoblastoma protein- and p53- deficient and proficient human osteosarcoma cell lines. 236
The p53-mediated sensitivity of cancer cells to chemotherapeutic agents is conditioned by the status of the retinoblastoma protein. 235
Location of rRNA transcription to the nucleolar components: disappearance of the fibrillar centers in nucleoli of regenerating rat hepatocytes. 234
A 41-gene signature predicts complete response (CR) to Bortezomib-Thalidomide-Dexamethasone (VTD) as induction therapy prior to autologous stem-cell transplantation (ASCT) in multiple myeloma (MM). 226
P53-dependent and p53-independent anticancer activity of a new indole derivative in human osteosarcoma cells 226
Analysis of EVs from patients with advanced pancreatic cancer identifies antigens and miRNAs with predictive value 225
RNA pseudouridylation in physiology and medicine: For better and for worse 225
Cell proliferation of esophageal squamous epithelium in erosive and non-erosive reflux disease 223
Novel dyskerin-mediated mechanism of p53 inactivation through defective mRNA translation. 219
Interleukin 6 downregulates p53 expression and activity by stimulating ribosome biogenesis: a new pathway connecting inflammation to cancer. 217
Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer. 215
Key role of the achievement of an appropriate ribosomal RNA complement for G1-S phase transition in H4-II-E-C3 rat hepatoma cells 211
The Ribosome Biogenesis-Cancer Connection 210
How Altered Ribosome Production Can Cause or Contribute to Human Disease: The Spectrum of Ribosomopathies 210
Epigenetic up-regulation of ribosome biogenesis and more aggressive phenotype triggered by the lack of the histone demethylase JHDM1B in mammary epithelial cells 210
Inhibition of human dyskerin as a new approach to target ribosome biogenesis. 208
Selective inhibition of rRNA transcription downregulates E2F-1: a new p53-independent mechanism linking cell growth to cell proliferation. 207
Cap-independent protein synthesis is enhanced by betaine under hypertonic conditions 206
5′-Untranslated region of heat shock protein 70 mRNA drives translation under hypertonic conditions 203
The balance between rRNA and ribosomal protein synthesis up- and downregulates the tumour suppressor p53 in mammalian cells. 202
Bromodomain Inhibition Is Effective Against Acute Myeloid Leukemia Cells Under Hypoxia and Induces Genome-Dependent Metabolic Perturbations 201
SnoRNA U50 levels are regulated by cell proliferation and rRNA transcription. 200
The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis 193
Initiation of mRNA Translation in Oncogenesis: The Role of eIF4E 191
The importance of being (slightly) modified: The role of rRNA editing on gene expression control and its connections with cancer 191
Mutational analysis of ribosomal proteins in a cohort of pediatric patients with T-cell acute lymphoblastic leukemia reveals Q123R, a novel mutation in RPL10 190
Dyskerin expression in human fetal, adult and neoplastic intrahepatic bile ducts: Correlations with cholangiocarcinoma aggressiveness 190
Changes in ribosome biogenesis may induce cancer by down-regulating the cell tumor suppressor potential. 188
Targeted inhibition of NMYC by peptide nucleic acid in N-myc amplified human neuroblastoma cells: cell-cycle inhibition with induction of neuronal cell differentiation and apoptosis 188
Relationship between the RB1 mRNA level and the expression of phosphorylated RB protein in human breast cancers: their relevance in cell proliferation activity and patient clinical outcome 187
Turning uridines around: Role of rRNA pseudouridylation in ribosome biogenesis and ribosomal function 186
ACETYL-CYSTEINE IMPROVES RESULTS OF LONG TERM CULTURE OF FROZEN/THAWED HUMAN OVARIAN TISSUE 183
Healthy early preantral follicle can be obtained in a culture of frozen-thawed human ovarian tissue of 32 weeks. 182
How snoRNAs can contribute to cancer at multiple levels 181
High prevalence of retinoblastoma protein loss in triple-negative breast cancers and its association with a good prognosis in patients treated with adjuvant chemotherapy. 181
COLTURE A LUNGO TERMINE (32 SETTIMANE) DI TESSUTO OVARICO UMANO CRIOCONSERVATO: EFFETTO DI IGF-II 179
COLTURE A LUNGO TERMINE (32 SETTIMANE) DI TESSUTO OVARICO UMANO CRIOCONSERVATO: EFFETTO DI FSH E LH 177
Exploitation of the ribosomal protein L10 R98S mutation to enhance recombinant protein production in mammalian cells 173
Primer extension coupled with fragment analysis for rapid and quantitative evaluation of 5.8S rRNA isoforms 173
The basal-like breast carcinoma phenotype is regulated by SLUG gene expression 172
Dyskerin and TERC expression may condition survival in lung cancer patients 172
Separated Siamese Twins: Intronic Small Nucleolar RNAs and Matched Host Genes May be Altered in Conjunction or Separately in Multiple Cancer Types 172
Liquid Biopsy in the Management of Breast Cancer Patients: Where Are We Now and Where Are We Going 169
JHDM1B expression regulates ribosome biogenesis and cancer cell growth in a p53 dependent manner 169
Prognostic relevance of a novel semi-quantitative classification of Bcl2 immunohistochemical expression in human infiltrating ductal carcinomas of the breast. 167
Relationship between dyskerin expression and telomerase activity in human breast cancer. 165
Ribosomal protein gene RPL9 variants can differentially impair ribosome function and cellular metabolism 165
Loss of Proteostasis Is a Pathomechanism in Cockayne Syndrome 162
Nucleolar size and activity are related to pRb and p53 status in human breast cancer 161
Loss of retinoblastoma tumor suppressor protein makes human breast cancer cells more sensitive to antimetabolite exposure. 160
Current practice in bicistronic ires reporter use: A systematic review 160
Controversial relationship between the expression of the RB pathway components and RB protein phosphorylation in human breast cancer 156
The emerging role of RNA polymerase I transcription machinery in human malignancy: a clinical perspective. 154
Decoding Ribosome Heterogeneity: A New Horizon in Cancer Therapy 153
What the nucleolus says to a tumour pathologist. 152
Alterations of ribosomal RNA pseudouridylation in human breast cancer 147
Nucleolus, ribosomes, and cancer. 145
Characterization of small nucleolar RNA retaining transcripts in human normal and cancer cells 142
Ribosomal RNA Pseudouridylation: Will Newly Available Methods Finally Define the Contribution of This Modification to Human Ribosome Plasticity? 140
null 139
Early monitoring of plasma KRAS G12C with digital PCR predicts antitumor response to immunotherapy or sotorasib in advanced NSCLC: A brief report 138
Beta-Catenin/HuR Post-Transcriptional Machinery Governs Cancer Stem Cell Features in Response to Hypoxia 136
DKC1 gene mutations in human sporadic cancer. 131
RiboAbacus: A model trained on polyribosome images predicts ribosome density and translational efficiency from mammalian transcriptomes 128
The wild type p53 codon 72 arginine allele is more permissive for hypoxia survival in cancer cells 128
null 128
Dyskerin depletion increases VEGF mRNA internal ribosome entry site-mediated translation. 124
Ribosome biogenesis and control of cell proliferation: p53 is not alone. 121
Dyskerin and cancer: more than telomerase. The defect in mRNA translation helps in explaining how a proliferative defect ends up in cancer. 114
Loss of function of the tumor suppressor DKC1 perturbs p27 translation control and contributes to pituitary tumorigenesis. 112
A combination of eicosapentaenoic acid-free fatty acid, epigallocatechin-3-gallate and proanthocyanidins has a strong effect on mTOR signaling in colorectal cancer cells. 107
Publisher Correction: A reconstituted cell-free assay for the evaluation of the intrinsic activity of purified human ribosomes 103
5.8S rRNA forms and ribosome heterogeneity in breast cancer 101
Role of JHDM1B in Breast Cancer Development and Progression - AIRC IG 11416 101
null 101
Defining the molecular pathogenesis of the ribosomopathy cartilage hair hypoplasia - Telethon Exploratory Grant GEP 15019 99
Ribosome biogenesis and cancer 98
null 89
Desmoplastic small round-cell tumor: A case report on the large cell variant with immunohistochemical, ultrastructural, and molecular genetic analysis 82
Role of dyskerin as a tumor suppressor in human cancer 81
null 81
Cytofluorimetric and functional analysis of c-kit receptor in acute leukemia 76
Primary endocervical extraosseous Ewing's sarcoma/PNET 75
null 69
Retinoic acid modulates stem cell factor secretion by human neuroblastoma cell lines 56
Enhanced telomere shortening in transformed lymphoblasts from patients with X linked dyskeratosis 49
Detection of fibronectin-binding protein genes in staphylococcal strains from peri-prosthesis infections 42
Qualitative and quantitative analysis of AgNOR proteins in chemically induced rat liver carcinogenesis 38
Totale 16.827
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.026
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.026
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.563 0 46 88 205 142 71 39 138 38 149 358 289
2022/20232.059 188 312 120 278 130 152 125 137 305 62 124 126
2023/2024558 57 76 20 63 54 98 29 44 17 30 37 33
2024/20252.399 101 309 216 154 359 133 282 109 20 196 108 412
2025/20265.456 426 641 481 399 563 300 435 165 1.193 423 180 250
2026/2027298 139 159 0 0 0 0 0 0 0 0 0 0
Totale 16.827